258 related articles for article (PubMed ID: 23704100)
1. A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
Gad SC; Sullivan DW; Crapo JD; Spainhour CB
Int J Toxicol; 2013 Jul; 32(4):274-87. PubMed ID: 23704100
[TBL] [Abstract][Full Text] [Related]
2. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
[TBL] [Abstract][Full Text] [Related]
3. Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation.
Makinde AY; Luo-Owen X; Rizvi A; Crapo JD; Pearlstein RD; Slater JM; Gridley DS
Anticancer Res; 2009 Jan; 29(1):107-18. PubMed ID: 19331139
[TBL] [Abstract][Full Text] [Related]
4. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
[TBL] [Abstract][Full Text] [Related]
5. A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness.
Moeller BJ; Batinic-Haberle I; Spasojevic I; Rabbani ZN; Anscher MS; Vujaskovic Z; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):545-52. PubMed ID: 16168847
[TBL] [Abstract][Full Text] [Related]
6. Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis.
Gad SC; Sullivan DW; Mujer CV; Spainhour CB; Crapo JD
Int J Toxicol; 2019; 38(4):291-302. PubMed ID: 31333066
[TBL] [Abstract][Full Text] [Related]
7. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.
Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME
Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417
[TBL] [Abstract][Full Text] [Related]
8. Manganese-porphyrin reactions with lipids and lipoproteins.
Bloodsworth A; O'Donnell VB; Batinic-Haberle I; Chumley PH; Hurt JB; Day BJ; Crow JP; Freeman BA
Free Radic Biol Med; 2000 Apr; 28(7):1017-29. PubMed ID: 10832063
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant.
Mackensen GB; Patel M; Sheng H; Calvi CL; Batinic-Haberle I; Day BJ; Liang LP; Fridovich I; Crapo JD; Pearlstein RD; Warner DS
J Neurosci; 2001 Jul; 21(13):4582-92. PubMed ID: 11425886
[TBL] [Abstract][Full Text] [Related]
10. Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity.
Shrishrimal S; Chatterjee A; Kosmacek EA; Davis PJ; McDonald JT; Oberley-Deegan RE
Free Radic Biol Med; 2020 May; 152():255-270. PubMed ID: 32222469
[TBL] [Abstract][Full Text] [Related]
11. Radioprotective effect of a metalloporphyrin compound in rat eye model.
Mao XW; Crapo JD; Mekonnen T; Lindsey N; Martinez P; Gridley DS; Slater JM
Curr Eye Res; 2009 Jan; 34(1):62-72. PubMed ID: 19172472
[TBL] [Abstract][Full Text] [Related]
12. Nonclinical Safety and Toxicokinetics of MnTnBuOE-2-PyP5+ (BMX-001).
Gad SC; Sullivan DW; Spasojevic I; Mujer CV; Spainhour CB; Crapo JD
Int J Toxicol; 2016 Jul; 35(4):438-53. PubMed ID: 27098749
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a metalloporphyrin antioxidant mimetic (MnTE-2-PyP) as a radiomitigator: prostate tumor and immune status.
Mehrotra S; Pecaut MJ; Freeman TL; Crapo JD; Rizvi A; Luo-Owen X; Slater JM; Gridley DS
Technol Cancer Res Treat; 2012 Oct; 11(5):447-57. PubMed ID: 22475066
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 mice.
Spasojević I; Chen Y; Noel TJ; Fan P; Zhang L; Rebouças JS; St Clair DK; Batinić-Haberle I
Free Radic Biol Med; 2008 Oct; 45(7):943-9. PubMed ID: 18598757
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
[TBL] [Abstract][Full Text] [Related]
16. Decreased hepatic ischemia-reperfusion injury by manganese-porphyrin complexes.
Wu TJ; Khoo NH; Zhou F; Day BJ; Parks DA
Free Radic Res; 2007 Feb; 41(2):127-34. PubMed ID: 17364938
[TBL] [Abstract][Full Text] [Related]
17. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.
Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I
Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564
[TBL] [Abstract][Full Text] [Related]
18. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
Kim TW; Kim KS; Seo JW; Park SY; Henry SP
J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
[TBL] [Abstract][Full Text] [Related]
20. Repeat oral dose toxicity studies of melamine in rats and monkeys.
Early RJ; Yu H; Mu XP; Xu H; Guo L; Kong Q; Zhou J; He B; Yang X; Huang H; Hu E; Jiang Y
Arch Toxicol; 2013 Mar; 87(3):517-27. PubMed ID: 23052191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
